CE Holdings (4320) investor relations material

Executive summary

• Achieved record-high revenue and profits for the first half, driven by large-scale EMR projects going live and earlier-than-expected project starts.

• Net sales for the six months ended March 31, 2026, rose 18.2% year-over-year to ¥10,877 million, with operating profit up 13.7% to ¥1,399 million and ordinary profit up 14.9% to ¥1,424 million.

• Net income attributable to parent company shareholders was ¥708 million, nearly flat year-over-year due to impairment losses from new business ventures.

Financial highlights

• Revenue for the first half rose 18.2% year-over-year to ¥10,877 million.

• Operating income increased 13.7% to ¥1,399 million; ordinary income up 14.9% to ¥1,424 million.

• Gross profit increased to ¥2,578 million from ¥2,284 million year-over-year, with gross margin improvement.

• Total assets grew to ¥14,091 million as of March 31, 2026, up from ¥12,746 million at September 30, 2025.

• Cash and cash equivalents at period end more than doubled to ¥7,083 million from ¥3,851 million a year earlier.

Outlook and guidance

• Full-year revenue forecast raised to ¥16,000 million, up 8.2% from the previous year.

• Full-year forecast for FY2026 projects net sales of ¥16,000 million (up 1.1% year-over-year), operating profit of ¥1,600 million (up 13.3%), and profit attributable to owners of parent of ¥870 million (up 12.1%).

• Operating income projected at ¥1,600 million (+11.5% YoY), net income at ¥870 million (+16.5% YoY, excluding special factors).

• Full-year EPS is forecast at ¥52.21.

• Dividend forecast for FY2026 is ¥24 per share at year-end.